Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology - Trinity Biotech ( NASDAQ:TRIB )

a week ago

DUBLIN, Ireland, Sept. 09, 2024 ( GLOBE NEWSWIRE ) -- Trinity Biotech plc TRIB, a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today provided an update on the continued development of its glucose biosensor ...

Ticker	Sentiment	Impact
TRIB	Somewhat Bullish	31 %